Picture of Tianjin Development Holdings logo

882 — Tianjin Development Holdings News Story

0.000.00%
hk flag iconLast trade - 00:00
UtilitiesConservativeSmall CapNeutral

Brief: Tianjin Development Says FY Total Operating Income For Tianjin Lisheng Pharmaceutical RMB1.15 Bln

March 24 (Reuters) - Tianjin Lisheng Pharmaceutical Co
Ltd  002393.SZ :
    * FY  TOTAL OPERATING INCOME FOR TIANJIN LISHENG
PHARMACEUTICAL
RMB1.15 BILLION VERSUS RMB1.09 BILLION
    * FY NET PROFIT ATTRIBUTABLE FOR TIANJIN LISHENG
PHARMACEUTICAL
RMB93.6 MILLION VERSUS RMB122.1 MILLION
    * BOD OF LISHENG PHARMACEUTICAL PROPOSED TO DISTRIBUTE A
CASH
DIVIDEND OF RMB3.00 (TAX INCLUSIVE) FOR EVERY 10 SHARES

Source text for Eikon:  ID:nHKS9F5ZR6 
Further company coverage:  002393.SZ 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Tianjin Development Holdings

See all news